Sanofi Spending $1.5 Billion in Germany to Boost Insulin Supply

GALWAY, IRELAND--August 13, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--French pharma company Sanofi (NASDAQ:SNY) (Paris, France) has confirmed plans to invest 1.3 billion euro (US$1.5 billion) to build a new insulin plant at its Frankfurt Höchst campus in Germany.

Within this article: Details Sanofi's German investment to boost insulin supply, project details and timeline, existing operations, recent French investment, Germany's new Pharmaceutical Strategy and recent investment by pharma majors